Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Cosmetics News & Events

Cosmetics News & Events

                        Meetings, Conferences & Workshops on Cosmetics Home
          Cosmetics
          Cosmetics News & Events
          FDA Issues Updated Instructions for Serious Adverse Event Reporting for Cosmetic ProductsCosmetics News & Events FDA Issues Updated Instructions for Serious Adverse Event Reporting for Cosmetic Products
  
  	
    Share
    Post
    Linkedin

    Email
    PrintCosmetics Constituent Update

December 14, 2023

Today, the U.S. Food and Drug Administration (FDA) is providing an update on ongoing activities related to serious adverse event reporting mandated by the Modernization of Cosmetics Regulation Act of 2022 (MoCRA), which are enforceable starting December 29, 2023.

A responsible person is required to report serious adverse events associated with the use of cosmetic products in the United States to FDA within 15 business days. The responsible person must include a copy of the label on or within the retail packaging of such cosmetic product. If the responsible person receives medical or other information about the adverse event within 1 year of the initial report to FDA, they must submit this new information to FDA within 15 business days.

A responsible person means the manufacturer, packer, or distributor of a cosmetic product whose name appears on the label of such cosmetic product in accordance with section 609(a) of the FD&C Act or section 4(a) of the Fair Packaging and Labeling Act.

A serious adverse event is an adverse event that:

(A) results in:
	death;
		a life-threatening experience;
		inpatient hospitalization;
		a persistent or significant disability or incapacity;
		a congenital anomaly or birth defect;
		an infection; or
		significant disfigurement (including serious and persistent rashes, second- or third-degree burns, significant hair loss, or persistent or significant alteration of appearance), other than as intended under conditions of use that are customary or usual; or
	(B) requires, based on reasonable medical judgment, a medical or surgical intervention to prevent an outcome described in (A) above.In November 2023, FDA updated the Modernization of Cosmetics Regulation Act of 2022 (MoCRA) Web page to recommend that industry responsible persons submit serious adverse event reports for cosmetics by using the current MedWatch Form 3500A that is downloadable and fillable at MedWatch: The FDA Safety Information and Adverse Event Reporting Program - Mandatory (PDF). Please submit the completed form along with information to support the report, such as scans of labels and images of the serious adverse event to FDA via email at: CosmeticAERS@fda.hhs.gov or by mail to:

FDA CDER Mail Center
Attn: Cosmetics MedWatch reports
White Oak Campus, Building 22, G0207
10903 New Hampshire Ave.
Silver Spring, MD 20993

FDA is developing a process for submitting electronic mandatory adverse event reports for cosmetics.

Update Announced Today

FDA has updated the instructions for MedWatch Form 3500A to make it easier for the industry responsible person to complete the form to report a serious adverse event for a cosmetic product.

FDA will provide more information on the launch date for electronic submission of serious adverse event reports for cosmetic products required by MoCRA in the coming months.

FDA strongly encourages electronic submission of serious adverse event reports, when available, to facilitate efficiency and timeliness of data submission and management for the agency.

For More Information

How to Report a Cosmetic Related Complaint

                                                                                  Content current as of:
      12/14/2023
              
              
Regulated Product(s)
		 CosmeticsCosmetics News & Events

          
                        Meetings, Conferences & Workshops on Cosmetics
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop